tradingkey.logo

Cosmos Health Inc

COSM
0.724USD
+0.049+7.20%
Close 11/05, 16:00ETQuotes delayed by 15 min
21.50MMarket Cap
LossP/E TTM

Cosmos Health Inc

0.724
+0.049+7.20%

More Details of Cosmos Health Inc Company

Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.

Cosmos Health Inc Info

Ticker SymbolCOSM
Company nameCosmos Health Inc
IPO dateMay 19, 2010
CEOMr. Grigorios Siokas
Number of employees149
Security typeOrdinary Share
Fiscal year-endMay 19
Address5 Agiou Georgiou, Pilea
CityTHESSALONIKI
Stock exchangeNASDAQ Capital Market Consolidated
CountryGreece
Postal code554 38
Phone303125363102
Websitehttps://www.cosmosholdingsinc.com/
Ticker SymbolCOSM
IPO dateMay 19, 2010
CEOMr. Grigorios Siokas

Company Executives of Cosmos Health Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.16M
--
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Theodoros C. Karkantzos
Mr. Theodoros C. Karkantzos
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.16M
--
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
Greece
921.13K
89.16%
United Arab Emirates (
130.79K
12.66%
SKOPJE North Macedonia
16.22K
1.57%
Croatia (Country)
10.68K
1.03%
Bulgaria
-49.00
0.00%
Other
-45.60K
-4.41%
By Business
By Region
No Data

Shareholding Stats

Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Siokas (Grigorios)
20.38%
Bovopoulos (Andreas D)
4.81%
Terzis (Georgios)
2.41%
BlackRock Institutional Trust Company, N.A.
0.89%
Geode Capital Management, L.L.C.
0.63%
Other
70.88%
Shareholders
Shareholders
Proportion
Siokas (Grigorios)
20.38%
Bovopoulos (Andreas D)
4.81%
Terzis (Georgios)
2.41%
BlackRock Institutional Trust Company, N.A.
0.89%
Geode Capital Management, L.L.C.
0.63%
Other
70.88%
Shareholder Types
Shareholders
Proportion
Individual Investor
28.16%
Investment Advisor
1.55%
Investment Advisor/Hedge Fund
0.78%
Research Firm
0.47%
Hedge Fund
0.39%
Venture Capital
0.12%
Bank and Trust
0.02%
Other
68.51%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
36
1.01M
3.33%
-1.80M
2025Q2
47
11.57M
40.24%
+2.60M
2025Q1
46
9.62M
37.58%
+3.08M
2024Q4
46
5.58M
24.01%
-722.90K
2024Q3
47
6.02M
25.89%
+3.46M
2024Q2
49
2.80M
72.05%
-1.10M
2024Q1
49
2.81M
72.29%
-1.10M
2023Q4
49
4.12M
85.37%
+1.50M
2023Q3
46
2.84M
75.97%
+428.48K
2023Q2
43
2.78M
79.39%
+787.97K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Siokas (Grigorios)
6.16M
20.38%
--
--
Aug 01, 2025
Bovopoulos (Andreas D)
1.45M
4.81%
-427.73K
-22.74%
Aug 13, 2025
Terzis (Georgios)
727.26K
2.41%
--
--
Aug 01, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.89%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
191.56K
0.63%
-2.56K
-1.32%
Jun 30, 2025
The Vanguard Group, Inc.
134.83K
0.45%
--
--
Jun 30, 2025
Virtu Americas LLC
104.42K
0.35%
+104.42K
--
Jun 30, 2025
Citadel Advisors LLC
96.73K
0.32%
+96.73K
--
Jun 30, 2025
UBS Financial Services, Inc.
62.38K
0.21%
+705.00
+1.14%
Jun 30, 2025
Bardakis (Nikolaos)
45.00K
0.15%
--
--
Aug 01, 2025
View more

Related ETFs

Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Date
Type
Ratio
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
KeyAI